Agdon, Amari Bloom M.

HRN: 25-53-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/07/2025
02/08/2025
ORAL
3.5ml
TID
AGE With Moderate Dehydration
Waiting Final Action 
02/07/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/07/2025
02/08/2025
ORAL
1.4ml
BID
AGE With Moderate Dehydration
Waiting Final Action 
02/08/2025
CEFUROXIME 750MG (VIAL)
02/08/2025
02/14/2025
IVT
180mg
Q8
AGE With Moderate Dehydration
Waiting Final Action 
02/12/2025
MUPIROCIN 2%, 15G (TUBE)
02/12/2025
02/18/2025
TOPICAL
2%
BID
Post Iv Site
Waiting Final Action 
02/12/2025
CEFTRIAXONE 1G (VIAL)
02/12/2025
02/18/2025
IV DRIP
550mg
OD
Febrile Neutropenia; Persistent Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: